glp-1 long-term side effects cancer Ozempic and Drugs: Risk of Severe GI Adverse Effects of Glucagon-Like
Description
Glucagon-like peptide-1 (GLP-1) is a hormone involved in glucose homeostasis and satiety regulation
When GLP-1 receptor agonists (GLP-1RAs) were first approved over a decade ago, their primary indication was simple: help people with Type 2 diabetes manage their blood sugar
The global GLP-1 market is estimated to grow from USD 49.3 billion in the current year to USD 157
Globally, 90% of diabetes patients have TIIDM
That third pathway matters
